Unlike classical DKA, which is often the first sign of type 1 diabetes in adolescents and young people, DKA linked to SGLT2 inhibitors can occur while blood glucose levels are below <250 mg/dL [152]. This evidence concerns the gene SLC5A2 and type 1 diabetes mellitus.